PROPHASE LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.07 USD | -4.16% |
|
+0.20% | +12.17% |
| May. 09 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
| May. 09 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Presentation Operator MessageOperator (Operator)Greetings and welcome to ProPhase Labs Shareho...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.07
USD
Average target price
18.5
USD
Spread / Average Target
+264.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.17% | 91.49M | |
| -16.80% | 8.79B | |
| +63.16% | 4.19B | |
| -4.07% | 2.48B | |
| -43.01% | 2.29B | |
| -4.82% | 1.97B | |
| -18.74% | 1.56B | |
| -40.24% | 1.22B | |
| +9.42% | 1.13B | |
| +19.68% | 933M |
- Stock Market
- Equities
- PRPH Stock
- News ProPhase Labs, Inc.
- Transcript : ProPhase Labs, Inc. - Shareholder/Analyst Call